Editorial: Multidisciplinary approach to interstitial lung disease associated with systemic rheumatic diseases

Editorial: Multidisciplinary approach to interstitial lung disease associated with systemic rheumatic diseases

Bibliographic Details
Main Authors:	Gianluca Sambataro, Stefano Palmucci, Fabrizio Luppi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-12-01
Series:	Frontiers in Medicine
Subjects:	interstitial lung disease rheumatoid arthritis antisynthetase syndrome systemic sclerosis idiopathic inflammatory myopathies (IIMs)
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2022.1112872/full

Similar Items

Patients with Interstitial Lung Disease Secondary to Autoimmune Diseases: How to Recognize Them?
by: Domenico Sambataro, et al.
Published: (2020-04-01)

Contribution of pulmonary function tests (PFTs) to the diagnosis and follow up of connective tissue diseases
by: Nicola Ciancio, et al.
Published: (2019-05-01)

CCL18 as a Biomarker of Interstitial Lung Disease (ILD) and Progressive Fibrosing ILD in Patients with Idiopathic Inflammatory Myopathies
by: Elisabetta Zanatta, et al.
Published: (2023-05-01)

Myositis-Specific and Myositis-Associated Antibodies in Fibromyalgia Patients: A Prospective Study
by: Gianluca Sambataro, et al.
Published: (2023-02-01)

The usual Interstitial pneumonia pattern in autoimmune rheumatic diseases
by: Fabrizio Luppi, et al.
Published: (2023-12-01)

Interstitial lung disease associated with inflammatory myositis: Autoantibodies, clinical phenotypes, and progressive fibrosis
by: Angela Ceribelli, et al.
Published: (2023-03-01)

A Case of Anti-Synthetase Syndrome Successfully Treated with Mycophenolate Mofetil and Rituximab but No Corticosteroids
by: Agnieszka Ewa Sieradzka, et al.
Published: (2022-07-01)

Quantitative Indexes and Clinical Studies of Lung HRCT in Patients with Anti-MDA5 Antibody-positive Iims with Different Prognoses and Clinical Studies
by: Mingxia ZHANG, et al.
Published: (2024-05-01)

FAPi PET/CT for assessment and visualisation of active myositis-related interstitial lung disease: a prospective observational pilot studyResearch in context
by: Kastriot Kastrati, et al.
Published: (2024-06-01)

Nailfold Videocapillaroscopy Is a Useful Tool to Recognize Definite Forms of Systemic Sclerosis and Idiopathic Inflammatory Myositis in Interstitial Lung Disease Patients
by: Domenico Sambataro, et al.
Published: (2020-04-01)

Functional Progression in Patients with Interstitial Lung Disease Resulted Positive to Antisynthetase Antibodies: A Multicenter, Retrospective Analysis
by: Giulia Dei, et al.
Published: (2020-09-01)

Scleroderma specific autoantibodies in rheumatoid arthritis and Sjögren's syndrome patients with interstitial lung disease: Prevalence and associations
by: Vasiliki Koulouri, et al.
Published: (2023-01-01)

[<sup>18</sup>F]FDG-PET/CT in Idiopathic Inflammatory Myopathies: Retrospective Data from a Belgian Cohort
by: Halil Yildiz, et al.
Published: (2023-07-01)

Antisynthetase syndrome with anti-oj antibody: A Case report and review of literature
by: Nayan Patel Sureja, et al.
Published: (2022-01-01)

Etiology and Pathogenesis of Rheumatoid Arthritis-Interstitial Lung Disease
by: Yerin Kim, et al.
Published: (2023-09-01)

Rheumatoid arthritis overlapping systemic sclerosis with interstitial lung disease
by: Catalina-Elena Ionescu, et al.
Published: (2023-06-01)

Association between the Lung Immune Prognostic Index and mortality in patients with idiopathic inflammatory myopathy-associated interstitial lung disease
by: Dan Luo, et al.
Published: (2023-01-01)

Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows
by: Giulia Cassone, et al.
Published: (2020-04-01)

Scleromyositis: A distinct novel entity within the systemic sclerosis and autoimmune myositis spectrum. Implications for care and pathogenesis
by: Margherita Giannini, et al.
Published: (2023-01-01)

Lung microbiome alterations in patients with anti-Jo1 antisynthetase syndrome and interstitial lung disease
by: Teresa Quintero-Puerta, et al.
Published: (2023-12-01)

Nonspecific interstitial pneumonia revealing an antisynthetase syndrome
by: Nedia Moussa, et al.
Published: (2022-11-01)

A Proof-of-Concept Analysis of Plasma-Derived Exosomal microRNAs in Interstitial Pulmonary Fibrosis Secondary to Antisynthetase Syndrome
by: Sara Bozzini, et al.
Published: (2022-11-01)

Clinical Characteristics of Patients with Idiopathic Inflammatory Myopathy and Risk Factors for the Development of Interstitial Lung Disease
by: LI Xingjun, LI Shuangrong, WANG Nan, WANG Xiangyu, CUI Ruomei, XU Jian, GUO Yulong, LIU Shuang
Published: (2024-05-01)

INTERSTITIAL LUNG DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS – FACTS AND PERSPECTIVE
by: Vanina Bozhilova, et al.
Published: (2022-02-01)

POLYMYOSITIS/DERMATOMIOSITIS: DIFFERENTIAL DIAGNOSIS
by: O. A. Antelava
Published: (2016-07-01)

Angiogenic T Cells: Potential Biomarkers for the Early Diagnosis of Interstitial Lung Disease in Autoimmune Diseases?
by: Verónica Pulito-Cueto, et al.
Published: (2022-04-01)

Proteomics: Potential techniques for discovering the pathogenesis of connective tissue diseases-interstitial lung disease
by: Yinlan Wu, et al.
Published: (2023-03-01)

Clinical features, prognostic factors, and survival of patients with antisynthetase syndrome and interstitial lung disease
by: Na Zhao, et al.
Published: (2022-08-01)

Integrated management of interstitial lung disease associated with rheumatoid arthritis - A case report
by: Buduru Sreenivasa Prasad, et al.
Published: (2021-01-01)

The Evolving Concept of the Multidisciplinary Approach in the Diagnosis and Management of Interstitial Lung Diseases
by: Stefano Sanduzzi Zamparelli, et al.
Published: (2023-07-01)

Targeting intracellular pathways in idiopathic inflammatory myopathies: A narrative review
by: Gaetano La Rocca, et al.
Published: (2023-03-01)

Microbiome features in bronchoalveolar lavage fluid of patients with idiopathic inflammatory myopathy-related interstitial lung disease
by: Liyan Zhang, et al.
Published: (2024-04-01)

Interstitial lung disease in rheumatoid arthritis
by: Laura Groseanu
Published: (2023-12-01)

Interstitial lung disease in rheumatoid arthritis: A multidisciplinary problem in rheumatology and pulmonology
by: E. L. Nasonov, et al.
Published: (2018-06-01)

Interstitial lung disease in rheumatoid arthritis: A multidisciplinary problem in rheumatology and pulmonology
by: E. L. Nasonov, et al.
Published: (2022-12-01)

Evolution of Rheumatoid-Arthritis-Associated Interstitial Lung Disease in Patients Treated with JAK Inhibitors: A Retrospective Exploratory Study
by: Vincenzo Venerito, et al.
Published: (2023-01-01)

Multidisciplinary discussion for diagnosis of interstitial lung disease in real life
by: Sabina Anna Guler, et al.
Published: (2016-05-01)

Safety and Effectiveness of Abatacept in a Prospective Cohort of Patients with Rheumatoid Arthritis–Associated Interstitial Lung Disease
by: Natalia Mena-Vázquez, et al.
Published: (2022-06-01)

Novel Biomarkers, Diagnostic and Therapeutic Approach in Rheumatoid Arthritis Interstitial Lung Disease—A Narrative Review
by: Alesandra Florescu, et al.
Published: (2022-06-01)

Periostin Is a Biomarker of Rheumatoid Arthritis-Associated Interstitial Lung Disease
by: Goushi Matama, et al.
Published: (2023-11-01)